1 period filed. Holdings below describe the selected month only.
NPORT-P · filed 2026-05-26
No share classes in the SEC snapshot.
2,774 filed series have no class in company_tickers_mf.json, so no ticker can be reached for them.
N-PORT Item C.4.a
N-PORT Item C.4.b
as filed
179 positions in this filing
| $0.00 HKD |
| 0.000% |
| HK |
| N/A SomaLogic, Inc. | — | 83444K113 US83444K1135 | DO OTHER | 1,418 NS | $0.00 | 0.000% | US |
| Swedish Krona | — | — — | STIV OTHER | 0.22 OU | $0.02 SEK | 0.000% | SE |
| N/A GeneDx Holdings Corp. | — | 81663L119 US81663L1199 | DO OTHER | 3,332 NS | $26.66 | 0.000% | US |
| Swiss Franc | — | — — | STIV OTHER | 198.45 OU | $248.19 CHF | 0.000% | CH |
| Danish Krone | — | — — | STIV OTHER | 2,203.13 OU | $340.77 DKK | 0.000% | DK |
| EURO | — | — — | STIV OTHER | 375.59 OU | $434.13 EUR | 0.000% | XX |
| Generation Bio Co. Generation Bio Co., CVR | — | 371CVR010 — | OTHER CORP | 3,013 NS | $2.4K | 0.001% | US |
| Cabaletta Bio, Inc. | CABA | 12674W109 US12674W1099 | EC CORP | 1,057 NS | $2.8K | 0.002% | US |
| N/A Revolution Medicines, Inc. | RVMDW | 76155X118 US76155X1182 | DO OTHER | 3,127 NS | $5.4K | 0.003% | US |
| Ginkgo Bioworks Holdings, Inc. Ginkgo Bioworks Holdings, Inc., Class A | DNA | 37611X209 US37611X2099 | EC CORP | 1,346 NS | $8.3K | 0.005% | US |
| Japanese Yen | — | — — | STIV OTHER | 2,091,383 OU | $13.2K JPY | 0.008% | JP |
| Tenax Therapeutics, Inc. | TENX | 88032L605 US88032L6056 | EC CORP | 842 NS | $13.5K | 0.008% | US |
| MediWound Ltd. | MDWD | — IL0011316309 | EC CORP | 946 NS | $15.2K | 0.010% | IL |
| Janux Therapeutics, Inc. | JANX | 47103J105 US47103J1051 | EC CORP | 1,122 NS | $15.6K | 0.010% | US |
| Nuvation Bio, Inc. | NUVB | 67080N101 US67080N1019 | EC CORP | 3,852 NS | $16.5K | 0.010% | US |
| Beta Bionics, Inc. | BBNX | 08659B102 US08659B1026 | EC CORP | 1,821 NS | $18.2K | 0.011% | US |
| Adlai Nortye Ltd. | ANL | 00704R109 US00704R1095 | EC CORP | 3,368 NS | $23.3K | 0.015% | KY |
| LENZ Therapeutics, Inc. | LENZ | 52635N103 US52635N1037 | EC CORP | 2,554 NS | $23.4K | 0.015% | US |
| RadNet, Inc. | RDNT | 750491102 US7504911022 | EC CORP | 423 NS | $23.6K | 0.015% | US |
| Monopar Therapeutics, Inc. | MNPR | 61023L207 US61023L2079 | EC CORP | 571 NS | $31.3K | 0.020% | US |
| Enliven Therapeutics, Inc. | ELVN | 29337E102 US29337E1029 | EC CORP | 800 NS | $31.4K | 0.020% | US |
| Immunovant, Inc. | IMVT | 45258J102 US45258J1025 | EC CORP | 1,300 NS | $32.3K | 0.020% | US |
| Saluda Medical, Inc. | — | — AU0000432114 | EC CORP | 57,441 NS | $32.9K AUD | 0.021% | US |
| Hims & Hers Health, Inc. | HIMS | 433000106 US4330001060 | EC CORP | 1,700 NS | $35.3K | 0.022% | US |
| Immix Biopharma, Inc. | IMMX | 45258H106 US45258H1068 | EC CORP | 5,000 NS | $45.5K | 0.029% | US |
| Aura Biosciences, Inc. | AURA | 05153U107 US05153U1079 | EC CORP | 7,297 NS | $48.8K | 0.031% | US |
| Eikon Therapeutics, Inc. | EIKN | 282564103 US2825641036 | EC CORP | 5,071 NS | $53.7K | 0.034% | US |
| Tectonic Therapeutic, Inc. | TECX | 878972108 US8789721086 | EC CORP | 1,900 NS | $58.7K | 0.037% | US |
| BridgeBio Oncology Therapeutics, Inc. BridgeBio Oncology Therapeutics, Inc., Class A | BBOT | 107924102 US1079241022 | EC CORP | 6,580 NS | $58.9K | 0.037% | US |
| Annexon, Inc. | ANNX | 03589W102 US03589W1027 | EC CORP | 10,634 NS | $58.9K | 0.037% | US |
| Rocket Pharmaceuticals, Inc. | RCKT | 77313F106 US77313F1066 | EC CORP | 16,956 NS | $60.7K | 0.038% | US |
| Immuneering Corp. Immuneering Corp., Class A | IMRX | 45254E107 US45254E1073 | EC CORP | 12,686 NS | $66.9K | 0.042% | US |
| Crescent Biopharma, Inc. | CBIO | — KYG2545C1042 | EC CORP | 4,414 NS | $81.1K | 0.051% | KY |
| Aktis Oncology, Inc. | AKTS | 01021M104 US01021M1045 | EC CORP | 4,864 NS | $87.0K | 0.055% | US |
| Evommune, Inc. | EVMN | 30054Y107 US30054Y1073 | EC CORP | 4,008 NS | $92.1K | 0.058% | US |
| Alto Neuroscience, Inc. | ANRO | 02157Q109 US02157Q1094 | EC CORP | 4,100 NS | $92.2K | 0.058% | US |
| Bicycle Therapeutics plc | BCYC | 088786108 US0887861088 | EC CORP | 20,819 NS | $96.6K | 0.061% | GB |
| Inspire Medical Systems, Inc. | INSP | 457730109 US4577301090 | EC CORP | 1,900 NS | $98.0K | 0.062% | US |
| Immatics NV | IMTX | — NL0015285941 | EC CORP | 10,100 NS | $99.4K | 0.063% | NL |
| Agios Pharmaceuticals, Inc. | AGIO | 00847X104 US00847X1046 | EC CORP | 2,991 NS | $101.2K | 0.064% | US |
| Zai Lab Ltd. | ZLAB | 98887Q104 US98887Q1040 | EC CORP | 5,474 NS | $103.0K | 0.065% | KY |
| Sensorion SA | — | — FR0012596468 | EC CORP | 227,583 NS | $108.5K EUR | 0.068% | FR |
| SpyGlass Pharma, Inc. | SGP | 85220G109 US85220G1094 | EC CORP | 4,214 NS | $109.2K | 0.069% | US |
| Xencor, Inc. | XNCR | 98401F105 US98401F1057 | EC CORP | 9,370 NS | $113.0K | 0.071% | US |
| Entrada Therapeutics, Inc. | TRDA | 29384C108 US29384C1080 | EC CORP | 9,365 NS | $118.2K | 0.074% | US |
| Viridian Therapeutics, Inc. | VRDN | 92790C104 US92790C1045 | EC CORP | 6,379 NS | $124.8K | 0.078% | US |
| Atrium Therapeutics, Inc. | RNA | 04965N104 US04965N1046 | EC CORP | 10,400 NS | $139.0K | 0.087% | US |
| Lantheus Holdings, Inc. | LNTH | 516544103 US5165441032 | EC CORP | 1,900 NS | $144.1K | 0.091% | US |
| Liquidia Corp. | LQDA | 53635D202 US53635D2027 | EC CORP | 3,938 NS | $148.6K | 0.093% | US |
Positions resolved to the master through ISIN, then rolled up through the taxonomy. 93.8% of reported value reaches a classification.
Percentages are of the reported value of positions above ($159.70M), not of the fund’s net assets ($158.96M). The two differ by cash, derivatives filed with no market value, and rounding.